• Welcome Guest
  • View Cart
  • Phone (US): 703.778.3080
  • 0Shopping Cart
  • Market Reports
  • Market Research Subscriptions
    • Knowledge Center
  • Custom Market Research
    • Quantitative Market Research
    • Qualitative Market Research
    • RateMyProduct
  • Blog
  • Featured
    • Free Downloads
    • View Webinars On-Demand
    • The IVD Market in 2023: $130 Billion and Growing
    • The Point of Care Testing Market
    • Immunoassays
  • About Us
    • Contact
  • Search
  • Menu Menu
  • Biotechnology
    • Next Generation Sequencing
    • Proteomics
    • Biopharmaceuticals
    • Instrumentation & Equipment
    • Emerging Technologies
  • Pharmaceuticals
    • Vaccines
    • Drug Delivery
    • Over-the-Counter
    • Drug Discovery
    • Cancer Treatment
    • Manufacturing & Packaging
    • Prescription Drugs
  • Diagnostics
    • Molecular Assays
    • Point-of-Care
    • Immunoassays
    • Infectious Disease
    • Clinical Chemistry
    • Oncology & Hematology
    • Lab Testing Services
    • Medical Imaging
  • Healthcare
    • Information Technology
    • Facilities & Settings
    • Insurance & Managed Care
  • Medical Devices
    • Wound Care
    • Drug Delivery
    • Equipment
    • Surgical
  • Login
Awaiting product image

Filter your search

Search Report Keyword
Price
CATEGORIES
  • Biotechnology Market Research
  • cell and gene therapy
  • cell therapy
  • Diagnostics Market Research
  • gene therapy
  • Healthcare Information Technology
  • Healthcare Market Research
  • in vitro diagnostic
  • IVD
  • life sciences
  • Medical Devices Market Research
  • Molecular & Nucleic Acid Testing
  • Pharmaceuticals Market Research
  • Point-of-Care Diagnostics
  • sciences
  • vaccines

Knowledge Center Sidebar

Most Popular Research

  • Cell and Gene Therapy Business Outlook
  • The Worldwide Market for In Vitro Diagnostic Tests, 14th Edition
  • Clinical Diagnostics MasterFile
  • The Global Market for Medical Devices, 11th Edition
  • The World Market for Molecular Diagnostics Tests, 10th Edition
  • Remote Patient Monitoring and Telehealth Markets, 12th Edition

The Global Glucose Monitoring Market: Forecasts to 2020

$1,995.00 – $3,995.00

Clear
SKU: KLI5687926 Category: Diagnostics Market Research Pages: 190
  • Description
  • Table of Contents
  • Latest reports

Description

Diabetes is a leading cause of death and disability in the worldwide. It increases the risk for heart disease, end-stage renal disease, blindness, amputation, and complications of pregnancy and is ranked as the sixth leading cause of death.    Disease prevalence is driving sales of monitoring equipment.  The glucose monitoring device and diabetes management market is focused on utilizing advancements recently introduced to provide easier-to-use products and more accurate glucose monitoring. 
This Kalorama information report, The Global Glucose Monitoring Market provides market estimates and forecasts for this important test category.  As part of its coverage, the report breaksout the revenues earned by the glucose monitoring industry into appropriate segments so that businesses can assess the right market opportunity for the area they compete in.  The report includes estimates and forecasts for the following segments:
 – Traditional Glucose Monitoring Devices
  • Meters
  • Test Strips
  • Lancets
  • Glycated Hemoglobin Devices

 – Continuous Glucose Monitoring Devices

  • Transmitters/Receivers
  • Sensors

 – HbA1c and other Market

There are many issues facing this industry. Some issues are helping to propel the market; while other issues are retarding growth forward. Issues and trends driving the market for glucose monitoring devices and diabetes management include:  New innovations, Reimbursement challenges, Recalls, Aging of the population, Increasing life expectancy, Healthcare spending trends, Advances in sensors, Health insurance portability, Cost cutting, Healthcare efficiency, Capacity challenges, Growing acceptance of mobile technologies and other factors. These are discussed at length in the report, as are their role in market growth.
In this global report, Kalorama identifies market size and forecast for Traditional Glucose Monitoring and Continuous Glucose Monitoring (CGM) both worldwide and for the following countries and regions:
  • United States 
  • Germany 
  • France 
  • Italy 
  • UK 
  • Japan 
  • Brazil 
  • Russia 
  • India 
  • China 
Although there are many participants in the market, a handful of companies continue to make a significant impact on the glucose monitoring devices and diabetes management market. A select few are discussed here, including:
  • Abbott Laboratories  
  • AgaMatrix  
  • Arkray, Inc 
  • Bayer Diabetes
  • Bionime Corporation  
  • DexCom, Inc.  
  • Echo Therapeutics  
  • Entra Health Systems LLC  
  • Fora Care, Inc 
  • Genesis Health Technologies  
  • GlySure Limited  
  • Insulet 
  • Johnson & Johnson 
  • Medtronic  
  • Nipro Diagnostics, Inc 
  • Nova Diabetes Care, Inc. 
  • Oak Tree International Holdings, Inc. 
  • Prodigy Diabetes Care, LLC 
  • Roche  
  • U.S. Diagnostics, Inc. 
Telephone interviews and email correspondence were the primary method of gathering information. For the purpose of this study, Kalorama Information conducted interviews with more than 14 key industry officials, consultants, health care providers, and government personnel. These sources were the primary basis in gathering information specifically relating to revenue and market share data presented in this report. Specific interviews with company representatives included marketing directors, division managers, and product representatives.
Additionally, Kalorama Information has nearly a decade of compiled industry contacts, technology knowledge and industry experience reporting on the patient management market segment, a market with parallel industry dynamics.Secondary sources such as company literature, databases, investment reports, and medical, information technology and business journals were used to complement primary information. Databases covering patient billings and units sold were significant resources for validating primary findings.

Table of Contents

EXECUTIVE SUMMARY

Market Overview

Scope and Methodology

Size and Growth of the Market

Market Participants

INTRODUCTION

Overview

Regulation of Glucose Metabolism

Hormone Regulation

Exercise

Stress

Etiology

Type I

Type 2

Gestational

Others

Risk Factors

Diagnostic Tests

Fasting Blood Sugar (FBS)

2-Hour Postprandial Blood Sugar (PPBS)

Random Blood Sugar

Glucose Tolerance Test

Glucose Urine Test

Glycated Hemoglobin (HbA1c)

Demographics

Population Growth

Global Population Trends

Aging of the Population

Global Population over 65

Diabetes Incidence and Prevalence

Global Impact of Diabetes

United States and Canada

Diabetes in Europe

Diabetes in Africa, Middle East, Asia Pacific

Diabetes in Latin America

Obesity

New Diabetes Monitoring Technologies

Wireless Technologies

Smartphones in Healthcare

Benefits of Healthcare Smartphones

Challenges in the Implementation of Smartphones in Healthcare Settings

Remote Monitoring

Cloud-Based Mobile Healthcare

Cloud Connectivity and Compatibility

EMR (EHR) Data Transfer Applications and Equipment

Technology Innovation

Technology for Drug Adherence, Targeted Delivery, and Monitoring

Mobile Medical Applications and Patient Monitoring

Apps for Diabetes Management

TRADITIONAL GLUCOSE MONITORING DEVICES AND DIABETES MANAGEMENT MARKET

Traditional Glucose Monitoring Devices and Diabetes Management

Overview

Glucose Meters, Test Strips and Lancets

Selected Product Examples

Glycated Hemoglobin

Selected Product Examples

New Product Innovations

Market Analysis

Markets by Product Segment

Markets by Application

Self-Testing

Professional Testing

Markets by Global Region

United States

Europe

Japan

Rest of World

Competitive Analysis

CONTINUOUS GLUCOSE MONITORING AND SENSOR MARKET

Introduction

Selected Product Examples

Market Analysis

Markets by Product Segment

Markets by Global Region

United States

Europe

Japan

Rest of World

Competitive Analysis

ISSUES AND TRENDS

Overview

New Innovations

Reimbursement Challenges

Recalls

Aging of the Population

Increasing Life Expectancy and the Demand for Advanced Healthcare Delivery

Options

Healthcare Spending Trends

U.S. Health Industry Trends

U.S. Healthcare Challenges

Advances in Sensors

Health Insurance Portability and Accountability Act (HIPAA)

Cost cutting

Healthcare Efficiency

Electronic Medical Records

Overview of EMRs

Data Management and the Electronic Medical Record

The EMR and Mobile Apps

Capacity Challenges

Emphasis on Reducing Hospital Days

Hospital Communications

Growing Acceptance of Mobile Technologies

Internet Users and Growing Adoption of Technology

FCC Rules for Medical Wireless Communication

System Compatibility

GLOBAL GLUCOSE MONITORING DEVICES AND DIABETES MANAGEMENT MARKET AND COMPETITOR ANALYSIS

Overview

Market Drivers and Inhibitors

Growth Drivers

Growth Inhibitors

Total Global Market Size and Forecast

Global Markets by Product Segment

MARKET ANALYSIS BY REGION

United States Market Overview

Markets by Product Type

European Market Overview

Markets by Product Type

Japan Market Overview

Markets by Product Type

Rest of World Market Overview

Markets by Product Type

CORPORATE PROFILES

Introduction

Profiles

Abbott Laboratories

Company Overview

Performance Review

AgaMatrix

Company Overview

ARKRAY, Inc

Company Overview

BAYER DIABETES CARE

Company Overview

Performance Review

Bionime Corporation

Company Overview

Performance Review

DexCom, Inc.

Company Overview

Performance Review

Echo Therapeutics

Company Overview

Entra Health Systems LLC

Company Overview

Fora Care, Inc

Company Overview

Genesis Health Technologies

Company Overview

GlySure Limited

Company Overview

Insulet

Company Overview

Performance Review

Johnson & Johnson

Company Overview

Performance Review

Medtronic

Company Overview

Performance Review

Nipro Diagnostics, Inc

Company Overview

Nova Diabetes Care, Inc.

Company Overview

Oak Tree International Holdings, Inc.

Company Overview

Prodigy Diabetes Care, LLC

Company Overview

Roche

Company Overview

Performance Review

U.S. Diagnostics, Inc.

Company Overview

LIST OF CONTRIBUTORS

LIST OF EXHIBITS

EXECUTIVE SUMMARY

Table 1-1

The Global Glucose Monitoring Devices and Diabetes Management Market 2013-2020

Figure 1-1

The Global Glucose Monitoring Devices and Diabetes Management Market 2013-20205

INTRODUCTION

Table 2-1

Global Population and Average Annual Change, 2005 – 2050

Figure 2-1

The Global Population, 2005-2050

Table 2-2

Global Population Trends Age 65+, 2000-2050

Figure 2-2

Global Population Trends Age 65+, 2000-2050

Table 2-3

United States and Canada Diabetes Statistics, 2014

Table 2-4

Europe Diabetes Statistics by Country, 2014

Table 2-5

Africa, Middle East, Asia Pacific Diabetes Statistics by Country, 2012

Table 2-6

Latin America Diabetes Statistics by Country, 2014

Figure 2-3

Percent of the Population that is Obese*, 2013 Estimates

TRADITIONAL GLUCOSE MONITORING DEVICES AND DIABETES

MANAGEMENT MARKET

Table 3-1

Selected Traditional Glucose Meters

Table 3-2

Selected HbA1c Devices

Table 3-3

Selected Noninvasive Glucose Monitoring Devices

Table 3-4

Selected Apps and Glucose Management IT

Table 3-5

The Global Market for Traditional Glucose Monitoring Devices and Diabetes

Management 2013-2020

Figure 3-1

The Global Market for Traditional Glucose Monitoring Devices and Diabetes

Management 2013-2020

Table 3-6

The Global Traditional Glucose Monitoring Devices and Diabetes Management Market by Product Segment 2013-2020

Figure 3-2

The Global Traditional Glucose Monitoring Devices and Diabetes Management Market by Product Segment (Transmitter/Receiver, Sensors) 2013-2020

Figure 3-3

Distribution of Sales for Global Glucose Monitoring Devices and Diabetes Management by Product Segment(Transmitter/Receiver, Sensors), 2015

Table 3-7

Global Traditional Glucose Monitoring Self-Testing Market Analysis, 2015-2020

Table -3-8

Global Traditional Glucose Monitoring Professional Testing Market Analysis, 2015- 2020

Table 3-9

Top Five EU Countries Traditional Glucose Monitoring Device and Diabetes Management Markets by Revenues and Percent 2015

Table 3-10

Top Four Rest of World Countries Traditional Glucose Monitoring Device and Diabetes Management Markets by Revenues and Percent 2015

Table 3-11

The Global Traditional Glucose Monitoring Device and Diabetes Management Market by Region, 2013-2020

Figure 3-4

The Global Traditional Glucose Monitoring Devices and Diabetes Management by Region 2013-2020

Figure 3-5

Distribution of Sales for Global Traditional Glucose Monitoring Devices and Diabetes Management Markets by Region, 2015

Table 3-12

Competitor Analysis, Global Traditional Glucose Monitoring Device and Diabetes Management Participants, 2015

Figure 3-6

Global Traditional Glucose Monitoring Device and Diabetes Management

Manufacturers by Percent 2015

CONTINUOUS GLUCOSE MONITORING AND SENSOR MARKET

Table 4-1

Selected Continuous Glucose Monitor Devices and Sensors

Table 4-2

Selected Continuous Blood Glucose Systems in Development, 2015

Table 4-3

The Global Continuous Glucose Monitoring and Sensor Market 2013-2020

Figure 4-1

The Global Continuous Glucose Monitoring and Sensor Market 2013-2020

Table 3-6

The Global Continuous Glucose Monitoring and Sensor Market by Product Segment 2013-2020

Figure 3-2

The Global Market for Continuous Glucose Monitoring and Sensor Market by Product Segment 2013-2020

Figure 3-3

Distribution of Sales for Global Continuous Glucose Monitoring and Sensor Market by Product Segment, 2015

Table 4-4

Top Five EU Countries Glucose Monitoring and Sensor Market by Revenues and Percent 2015

Table 4-5

Top Four Rest of World Countries Continuous Glucose Monitoring and Sensor Market by Revenues and Percent 2015

Table 4-6

The Global Continuous Glucose Monitoring and Sensor Market by Region, 2013-2020

Figure 4-2

The Global Continuous Glucose Monitoring and Sensor Market by Region 2013-202087

Figure 4-3

Distribution of Sales for Global Continuous Glucose Monitoring and Sensor Market by Region, 2015

Table 4-7

Competitor Analysis, Global Continuous Glucose Monitoring and Sensor Market Participants, 2015

Figure 4-4

Global Continuous Glucose Monitoring and Sensor Market Manufacturers by Percent

2015

ISSUES AND TRENDS

Table 5-1

Summary of Abbott Diabetes Care Recalls

Table 5-2

National Healthcare Expenditures in the United States 1960-2020

Figure 5-1

Healthcare Spending as a Percent of GDP in the United States, 1980-2020

Table 5-3

Technology Adoption

Figure 5-2

Percent of Population Using the Internet by Region, 2014

GLOBAL GLUCOSE MONITORING DEVICES AND DIABETES

MANAGEMENT MARKET AND COMPETITOR ANALYSIS

Table 6-1

The Global Glucose Monitoring Device and Diabetes Management Market 2013-2020

Figure 6-1

The Global Glucose Monitoring Device and Diabetes Management Market 2013-2020

Table 6-2

The Global Glucose Monitoring Devices and Diabetes Management Market by Product

Segment(Monitors, Test Strips, Lancets, Others) 2013-2020

Figure 6-2

The Global Glucose Monitoring Devices and Diabetes Management Market by Product

Segment(Monitors, Test Strips, Lancets, Others), 2013-2020

Figure 6-3

Distribution of Sales for Global Glucose Monitoring Devices and Diabetes Management

Market by Product Segment(Monitors, Test Strips, Lancets, Others), 2015

Table 6-3

The Global Glucose Monitoring Devices and Diabetes Management Market by Region,

2013-2020

Figure 6-4

The Global Glucose Monitoring Devices and Diabetes Management Market by Region

2013-2020

Figure 6-5

Global Glucose Monitoring Devices and Diabetes Management Market, Distribution of

Sales by Region, 2015

Figure 6-6

United States: Glucose Monitoring Devices and Diabetes Management Market 2013-

2020

Table 6-4

United States: Glucose Monitoring Devices and Diabetes Management Market by

Product Segment (Traditional Glucose Monitoring, CGM) 2015

Figure 6-7

United States: Glucose Monitoring Devices and Diabetes Management Market by

Product Segment(Traditional Glucose Monitoring, CGM), 2015

Figure 6-8

Europe: Glucose Monitoring Devices and Diabetes Management Market, 2013-2020133

Table 6-5

Europe: Glucose Monitoring Devices and Diabetes Management Market by Product

Segment(Traditional Glucose Monitoring, CGM) 2015

Figure 6-9

Europe: Glucose Monitoring Devices and Diabetes Management Market by Product

Segment(Traditional Glucose Monitoring, CGM), 2015

Figure 6-10

Japan: Glucose Monitoring Devices and Diabetes Management Market 2013-2020

Table 6-6

Japan: Glucose Monitoring Devices and Diabetes Management Market by Product

Segment(Traditional Glucose Monitoring, CGM) 2015

Figure 6-11

Japan: Glucose Monitoring Devices and Diabetes Management Market by Product

Segment(Traditional Glucose Monitoring, CGM), 2015

Table 6-7

Rest of World: Glucose Monitoring and Diabetes Management Market 2013-2020

Table 6-8

Rest of World: Glucose Monitoring Devices and Diabetes Management Market by

Product Segment(Traditional Glucose Monitoring, CGM) 2015

Figure 6-12

Rest of World: Glucose Monitoring Devices and Diabetes Management Market by

Product Segment(Traditional Glucose Monitoring, CGM), 2015

CORPORATE PROFILES

Figure 7-1

Abbott’s Financial Performance, 2011-2015

Figure 7-2

Bionime’s Financial Performance, 2011-2015

Figure 7-3

DexCom’s Financial Performance, 2011-2015

Figure 7-4

Insulet’s Financial Performance, 2011-2015

Figure 7-5

Johnson & Johnson’s Financial Performance, 2011-2015

Figure 7 -6

Medtronic’s Financial Performance, 2011-2015

Figure 7-7

Roche’s Financial Performance, 2011-2015

LIST OF CONTRIBUTORS

 

    Worldwide Market for Point-of-Care (POC) Diagnostic Tests, 12th Edition
    May 13, 2025
    In Vitro Diagnostic (IVD) Trends and Market Update, 2025
    April 7, 2025
    In Vitro Diagnostics Business Outlook, 2025 (6 Issues)
    April 3, 2025
    Molecular Diagnostics Quarterly Datastream, 2025
    April 2, 2025

Related products

  • Placeholder image

    Blood – The Worldwide Market for Blood Products, Blood Testing, Blood Equipment, and Synthetic Blood Products

    $1,995.00 – $7,800.00
  • Placeholder image

    Diagnostics for Emerging Infectious Disease Threats Volume II: Viral Disease

    $1,496.00 – $2,992.00
  • Placeholder image

    Clinical Diagnostics in China – Market Sector Analyses and Participant Directory

    $4,995.00 – $9,990.00
  • Placeholder image

    Nucleic Acid-Based Therapeutics: World Markets, Developments, and Applications

    $3,500.00 – $7,000.00

Contact Us

  • 671 North Glebe Road, Suite 1610 Arlington, VA 22203 United States

  • Email Us

  • 703-778-3080

  • Send us a message!

Pay Invoice

  • Pay an Invoice by Credit Card

Follow Us!

Latest Blogs

  • 4 Fascinating Facts About Cancer Diagnostics March 4, 2025
  • Food Animal Diagnostics Market: Spotlight on Disease Testing Amid Bird Flu Surge February 20, 2025
  • Custom Competitive Intelligence (CI) Research: A New Strategic Imperative For Lab Diagnostics Companies  February 19, 2025
  • The Rise of Pharmacodiagnostics in the $10 Billion Global Cancer Diagnostics Market February 1, 2025
  • IVD Trends to Watch: Personalized Medicine Adds Precision to Diagnostic Testing January 2, 2025

Sitemap

  • Home
  • About
  • Blog
  • Contact
  • Sitemap

Your Data and Privacy

  • View our Privacy Policy
  • GDPR Statement
  • Privacy Settings

About Us

Kalorama Information, part of Science and Medicine Group, has been a leading publisher of market research in medical markets, including the biotechnology, diagnostics, medical device, and pharmaceutical industries for more than 30 years. Our comprehensive, timely, quality research and innovative approach to analysis and presentation of market intelligence have made Kalorama Information a premier source of market information for top industry decision makers.

Visit Science and Medicine Group
The World Market for Cancer Diagnostics, 2014-2019, 6th Edition (Histology [ISH,...The World Market for Molecular Diagnostics, 2014-2019, 6th Edition (Microbiology,...
Scroll to top